An Occlusive Hydrocolloid-Based Patch Is Effective, Feasible, and Safe As a Treatment of Irritant Contact Dermatitis Due to Diabetes Devices in Children and Adolescents with Type 1 Diabetes
Authors' conclusion
The hydrocolloid-based patch showed signs of faster healing of ICD with no additional AEs, but larger studies are needed.
Study context
- Population
- Children and adolescents aged 6–20 years with T1D and active irritant contact dermatitis (ICD) caused by diabetes devices
- Comparison
- Occlusive hydrocolloid-based patch vs nonocclusive treatment of ICD
- Outcome
- ICD healed completely
Methodological detailssingle-centre, cross-over
- Single-centre
- Cross-over
Main finding
As reported in the abstract
Patch
21%
Controls
0
events
Safety
Adverse events
- Additional adverse event (AE) in patch arm: infection at a different site from investigated
- 1
- Itching reported as an AE in both arms
Original publication
An Occlusive Hydrocolloid-Based Patch Is Effective, Feasible, and Safe As a Treatment of Irritant Contact Dermatitis Due to Diabetes Devices in Children and Adolescents with Type 1 Diabetes. Diabetes Technol Ther. Published 27 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →